deltatrials
Completed PHASE4 NCT00203450

Zonegran for the Treatment of Weight Gain Associated With Psychotropic Medication Use: A Placebo-Controlled Trial

Sponsor: Eisai Inc.

Conditions Obesity
Interventions Placebo Zonegran
Updated 6 times since 2017 Last updated: Aug 30, 2012 Started: May 31, 2003 Primary completion: Mar 31, 2005 Completion: Mar 31, 2006

Listed as NCT00203450, this PHASE4 trial focuses on Obesity and remains completed. Sponsored by Eisai Inc., it has been updated 6 times since 2003, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Change History

6 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE4

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE4

  5. Feb 2017 — Jun 2018 [monthly]

    Completed PHASE4

▶ Show 1 earlier version

  1. Jan 2017 — Feb 2017 [monthly]

    Completed PHASE4

    First recorded

May 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Eisai Inc.
  • Tuscaloosa Research & Education Advancement Corporation
Data source: Tuscaloosa Research & Education Advancement Corporation

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Tuscaloosa, United States